BRAF mutational analysis in ovarian tumors: recent perspectives
Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series
Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer
Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor
Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum
Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
Molecular targeting of low-grade serous and mucinous carcinomas of the ovary or peritoneum
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas
The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer
Updates and emerging therapies for rare epithelial ovarian cancers: one size no longer fits all
Previous
Previous
2016
Next
Next